Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Icosavax Initiates Phase 1/2 Trial of COVID-19 VLP Vaccine Candidate
Wednesday, June 09, 2021Icosavax Inc today announced the first subjects have been dosed with IVX a viruslike particle VLP displaying the SARSCoV receptorbinding domain RBD in a Phase clinical trial As previously announced the Phase trial is being funded by the Bill Melin...
Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel
Tuesday, June 08, 2021Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines and Medison Pharma a leading commercial partner for highly innovative therapies in international markets today announced a new agreement to commercialize the...
BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA
Tuesday, June 08, 2021BioCelerate a subsidiary of TransCelerate BioPharma Inc that focuses on identifying and developing pragmatic and tangible solutions to improve efficiencies in nonclinical research today announced that it has released the first set of its solutions as...
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication
Monday, June 07, 2021Ascletis Pharma Inc announces that China National Medical Products Administration NMPA has approved the Investigational New Drug IND application for its drug candidate ASC to conduct clinical trials for chronic hepatitis B CHB indication ASC is an in...
POINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPC
Saturday, June 05, 2021POINT Biopharma Inc POINT a global radiopharmaceutical company dedicated to successfully delivering precision radioligand therapy to cancer patients today announced that it has successfully dosed multiple patients in its Phase SPLASH study evaluatin...
Bayer acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancer
Friday, June 04, 2021Bayer today announced that it has entered into an agreement to acquire Noria Therapeutics Inc Noria and PSMA Therapeutics Inc Through this acquisition Bayer will obtain exclusive rights to a differentiated alpha radionuclide therapy based on actinium...
BioCryst Launches ORLADEYO™ (berotralstat) in Germany
Friday, June 04, 2021BioCryst Pharmaceuticals Inc today announced that oral oncedaily ORLADEYO berotralstat is now available for patients with a prescription in Germany ORLADEYO was approved by the European Medicines Agency EMA on April for the prevention of recurrent...
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement
Thursday, June 03, 2021GenScript Biotech Corporation along with its subsidiary GenScript ProBio and Ligand Pharmaceuticals Incorporated announced today that they have entered into a strategic licensing agreement for Ligands OmniAb Platform a multispecies antibody discovery...
Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase for Human and Animal Therapeutics
Thursday, June 03, 2021Primordial Genetics a synthetic biology company developing enzymatic production systems for nucleic acids today announced granting Arcturus Therapeutics Holdings Inc a clinicalstage messenger RNA mRNA medicines company an exclusive license of an enzy...
Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine
Wednesday, June 02, 2021Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines today announced that it has entered into an agreement with Thermo Fisher Scientific NYSE TMO for fillfinish sterile manufacturing services and supply packagin...
